181 related articles for article (PubMed ID: 16359931)
21. The contribution of endogenous sources of DNA damage to the multiple mutations in cancer.
Jackson AL; Loeb LA
Mutat Res; 2001 Jun; 477(1-2):7-21. PubMed ID: 11376682
[TBL] [Abstract][Full Text] [Related]
22. Cancer cells exhibit a mutator phenotype.
Loeb LA
Adv Cancer Res; 1998; 72():25-56. PubMed ID: 9338073
[TBL] [Abstract][Full Text] [Related]
23. Large-scale N-terminal deletions but not point mutations stabilize beta-catenin in small bowel carcinomas, suggesting divergent molecular pathways of small and large intestinal carcinogenesis.
Breuhahn K; Singh S; Schirmacher P; Bläker H
J Pathol; 2008 Jul; 215(3):300-7. PubMed ID: 18491352
[TBL] [Abstract][Full Text] [Related]
24. Human cancers express a mutator phenotype.
Bielas JH; Loeb KR; Rubin BP; True LD; Loeb LA
Proc Natl Acad Sci U S A; 2006 Nov; 103(48):18238-42. PubMed ID: 17108085
[TBL] [Abstract][Full Text] [Related]
25. Short telomeres resulting from heritable mutations in the telomerase reverse transcriptase gene predispose for a variety of malignancies.
Hills M; Lansdorp PM
Ann N Y Acad Sci; 2009 Sep; 1176():178-90. PubMed ID: 19796246
[TBL] [Abstract][Full Text] [Related]
26. [Molecular changes in development and progression of urothelial carcinoma].
Hartmann A
Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910
[TBL] [Abstract][Full Text] [Related]
27. Most spontaneous tumors in a mouse model of Li-Fraumeni syndrome do not have a mutator phenotype.
Hill KA; Buettner VL; Heidt A; Chen LL; Li W; Gonzalez KD; Wang JC; Scaringe WA; Sommer SS
Carcinogenesis; 2006 Sep; 27(9):1860-6. PubMed ID: 16597646
[TBL] [Abstract][Full Text] [Related]
28. The random amplified polymorphic DNA (RAPD) assay and related techniques applied to genotoxicity and carcinogenesis studies: a critical review.
Atienzar FA; Jha AN
Mutat Res; 2006; 613(2-3):76-102. PubMed ID: 16979375
[TBL] [Abstract][Full Text] [Related]
29. Epidermal growth factor receptor activation in prostate cancer by three novel missense mutations.
Cai CQ; Peng Y; Buckley MT; Wei J; Chen F; Liebes L; Gerald WL; Pincus MR; Osman I; Lee P
Oncogene; 2008 May; 27(22):3201-10. PubMed ID: 18193092
[TBL] [Abstract][Full Text] [Related]
30. TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes.
Petitjean A; Achatz MI; Borresen-Dale AL; Hainaut P; Olivier M
Oncogene; 2007 Apr; 26(15):2157-65. PubMed ID: 17401424
[TBL] [Abstract][Full Text] [Related]
31. A stem cell fusion model of carcinogenesis.
He X; Tsang TC; Pipes BL; Ablin RJ; Harris DT
J Exp Ther Oncol; 2005; 5(2):101-9. PubMed ID: 16471036
[TBL] [Abstract][Full Text] [Related]
32. DNA deletions and clonal mutations drive premature aging in mitochondrial mutator mice.
Vermulst M; Wanagat J; Kujoth GC; Bielas JH; Rabinovitch PS; Prolla TA; Loeb LA
Nat Genet; 2008 Apr; 40(4):392-4. PubMed ID: 18311139
[TBL] [Abstract][Full Text] [Related]
33. Somatic mutations in human cancer: insights from resequencing the protein kinase gene family.
Futreal PA; Wooster R; Stratton MR
Cold Spring Harb Symp Quant Biol; 2005; 70():43-9. PubMed ID: 16869737
[TBL] [Abstract][Full Text] [Related]
34. Transforming pathways unleashed by a HDAC2 mutation in human cancer.
Ropero S; Ballestar E; Alaminos M; Arango D; Schwartz S; Esteller M
Oncogene; 2008 Jun; 27(28):4008-12. PubMed ID: 18264134
[TBL] [Abstract][Full Text] [Related]
35. A mild mutator phenotype arises in a mouse model for malignancies associated with neurofibromatosis type 1.
Garza R; Hudson RA; McMahan CA; Walter CA; Vogel KS
Mutat Res; 2007 Feb; 615(1-2):98-110. PubMed ID: 17208258
[TBL] [Abstract][Full Text] [Related]
36. Dissecting the molecular mechanisms of cancer through bioinformatics-based experimental approaches.
Rivenbark AG; Coleman WB
J Cell Biochem; 2007 Aug; 101(5):1074-86. PubMed ID: 17372928
[TBL] [Abstract][Full Text] [Related]
37. Chromosome instability and tumor lethality suppression in carcinogenesis.
Shen C; Zhou Y; Zhan J; Reske SN; Buck AK
J Cell Biochem; 2008 Dec; 105(6):1327-41. PubMed ID: 18821574
[TBL] [Abstract][Full Text] [Related]
38. Allelic loss and mutations in a new ETRG-1 gene are early events in diethylstilbestrol-induced renal carcinogenesis in Syrian hamsters.
Singh KP; Roy D
Gene; 2008 Jan; 408(1-2):18-26. PubMed ID: 18068315
[TBL] [Abstract][Full Text] [Related]
39. Methylation and repeats in silent and nonsense mutations of p53.
Kouidou S; Malousi A; Maglaveras N
Mutat Res; 2006 Jul; 599(1-2):167-77. PubMed ID: 16620878
[TBL] [Abstract][Full Text] [Related]
40. Aberrant AID expression and human cancer development.
Marusawa H
Int J Biochem Cell Biol; 2008; 40(8):1399-402. PubMed ID: 18329947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
